Editas Medicine (EDIT) EPS (Weighted Average and Diluted): 2019-2025
Historic EPS (Weighted Average and Diluted) for Editas Medicine (EDIT) over the last 5 years, with Sep 2025 value amounting to -$0.28.
- Editas Medicine's EPS (Weighted Average and Diluted) rose 62.67% to -$0.28 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.38, marking a year-over-year increase of 6.30%. This contributed to the annual value of -$2.88 for FY2024, which is 42.57% down from last year.
- Per Editas Medicine's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.28 for Q3 2025, which was up 55.56% from -$0.63 recorded in Q2 2025.
- In the past 5 years, Editas Medicine's EPS (Weighted Average and Diluted) ranged from a high of -$0.21 in Q4 2023 and a low of -$0.92 during Q1 2025.
- Over the past 3 years, Editas Medicine's median EPS (Weighted Average and Diluted) value was -$0.63 (recorded in 2025), while the average stood at -$0.61.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first crashed by 575.00% in 2021, then skyrocketed by 76.14% in 2023.
- Over the past 5 years, Editas Medicine's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.61 in 2021, then crashed by 44.26% to -$0.88 in 2022, then spiked by 76.14% to -$0.21 in 2023, then crashed by 161.90% to -$0.55 in 2024, then skyrocketed by 62.67% to -$0.28 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.28 in Q3 2025, compared to -$0.63 in Q2 2025 and -$0.92 in Q1 2025.